UBS raised the firm’s price target on IBM (IBM) to $160 from $150 and keeps a Sell rating on the shares. A slower than expected recovery in IT demand and a tough comp from the recognition of a $241M pre-tax gain in Q1 creates risk, while the strength in the US Dollar relative to the Euro, Pound, and Yen during Q4 will create a larger revenue headwind than expected, the analyst tells investors in a research note. The rise in tech valuations and the S&P is a “key factor” however in the firm assuming a higher multiple in its price to earnings valuation, UBS adds.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- The Human Signature in a Time of AI and Quantum Computing
- Quantum Computing News: The Latest Advancements from Industry Giants
- IBM price target raised to $215 from $210 at Bernstein
- IBM and GlobalFoundries End Legal Disputes
- IBM, GlobalFoundries announce settlement, resolution of all litigation matters